FLULAVAL

STN: 125163
Proper Name: Influenza Vaccine
Tradename: FLULAVAL
Manufacturer: ID Biomedical Corporation of Quebec dba GlaxoSmithKline Biologicals
Indication: Active immunization against influenza in individuals 6 months and older.

Product Information

• Package Insert - FLULAVAL

Supporting Documents

• March 23, 2026 Approval Letter - FLULAVAL
• July 1, 2025 Approval Letter - FLULAVAL
• July 1, 2024 Approval Letter - FLULAVAL
• February 6, 2020 Approval Letter - FLULAVAL
• Statistical Review and Evaluation - FluLaval and FluLaval Quadrivalent
• Statistical Review Assay - FluLaval and FluLaval Quadrivalent
• Clinical Review - FluLaval and FluLaval Quadrivalent
• Supporting Documents older than three years - FluLaval